Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9137 |
High Similarity |
NPD1607 |
Approved |
0.9085 |
High Similarity |
NPD1549 |
Phase 2 |
0.9014 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9014 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9007 |
High Similarity |
NPD1510 |
Phase 2 |
0.8993 |
High Similarity |
NPD1240 |
Approved |
0.8973 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8944 |
High Similarity |
NPD2796 |
Approved |
0.8874 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8808 |
High Similarity |
NPD1934 |
Approved |
0.8758 |
High Similarity |
NPD3882 |
Suspended |
0.875 |
High Similarity |
NPD7819 |
Suspended |
0.8716 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8681 |
High Similarity |
NPD1551 |
Phase 2 |
0.8675 |
High Similarity |
NPD6599 |
Discontinued |
0.8649 |
High Similarity |
NPD6799 |
Approved |
0.8649 |
High Similarity |
NPD1511 |
Approved |
0.8627 |
High Similarity |
NPD2801 |
Approved |
0.8618 |
High Similarity |
NPD7411 |
Suspended |
0.8581 |
High Similarity |
NPD7075 |
Discontinued |
0.8571 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD4380 |
Phase 2 |
0.8535 |
High Similarity |
NPD6959 |
Discontinued |
0.8533 |
High Similarity |
NPD1512 |
Approved |
0.8506 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8435 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8375 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8333 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8322 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8272 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8182 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8165 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8125 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8113 |
Intermediate Similarity |
NPD3749 |
Approved |
0.811 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8108 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD943 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8013 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8013 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8 |
Intermediate Similarity |
NPD920 |
Approved |
0.8 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7974 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7972 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7908 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7871 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD919 |
Approved |
0.7823 |
Intermediate Similarity |
NPD411 |
Approved |
0.7817 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7806 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7762 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7762 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7756 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7744 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7703 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7667 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7569 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7562 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7548 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7516 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7431 |
Intermediate Similarity |
NPD17 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7293 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD9494 |
Approved |
0.726 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7205 |
Intermediate Similarity |
NPD4662 |
Approved |
0.72 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7151
|
Intermediate Similarity |
NPD4287 |
Approved |